Product NDC: | 0186-0702 |
Proprietary Name: | ENTOCORT |
Non Proprietary Name: | Budesonide |
Active Ingredient(s): | 3 mg/1 & nbsp; Budesonide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0186-0702 |
Labeler Name: | AstraZeneca LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021234 |
Marketing Category: | NDA |
Start Marketing Date: | 20011029 |
Package NDC: | 0186-0702-10 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0186-0702-10) |
NDC Code | 0186-0702-10 |
Proprietary Name | ENTOCORT |
Package Description | 100 CAPSULE in 1 BOTTLE (0186-0702-10) |
Product NDC | 0186-0702 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Budesonide |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20011029 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca LP |
Substance Name | BUDESONIDE |
Strength Number | 3 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |